← All Cases Coverage by Bryan K. Randolph · BrynoDC

FDA v. Alliance for Hippocratic Medicine

No. 23-10362 SCOTUS · Decided Teaching/Historical SCOTUS
Argued: May 17, 2023 Decided: Sep 16, 2024
Court
5th Cir.
ca5
Argued
May 17, 2023
Decided
Sep 16, 2024
Filed
Apr 10, 2023
Filed (CL)
Apr 10, 2023
CL Status
terminated

Case Overview

In 2024, the Supreme Court ruled 9-0 that a group of anti-abortion doctors lacked standing to challenge the FDA's approval of mifepristone — the medication used in the majority of U.S. abortions — because they couldn't show any personal injury from its approval or use. The unanimous decision made it as much a case about access to courts as about abortion: disagreeing with a policy isn't enough to sue over it; you have to show the policy actually harmed you specifically. Bryan covers it as a standing case, and a reminder that 9-0 opinions are rare enough to mean something — when every justice agrees, the legal question is clean.

Legal Issues

Mifepristone; standing; APA; reproductive rights; no standing found

BrynoDC Coverage 2 videos

TikTok
Jan 14, 2026
TikTok

The Conclusion

**Alliance for Hippocratic Medicine demonstrates standing doctrine's clarity: the Supreme Court unanimously held that plaintiffs must demonstrate concrete injury, not policy disagreement.** Anti-abortion physicians challenging the FDA's mifepristone approval failed to show they were personally harmed. The 9-0 decision illustrated how settled this constitutional gate-keeping principle remains.

SCOTUS TMR-6a3573bf May 28, 2026

Cited By (16)

Subscribe on Substack ↗

This tracker is maintained by BrynoDC and is free because readers fund it. Support